TRPV1 and cancer: The data presented here thus suggest a possible role for endocannabinoids/endovanilloids in the pathogenesis of EC and although TRPV1 activation holds promise as a potential therapeutic target in certain cancers, it relevance and efficacy in EC warrant further investigation and validation.